PYXS logo

Pyxis Oncology (PYXS)

Profile

Full Name

Pyxis Oncology, Inc.

Ticker Symbol

PYXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 8, 2021

Indexes

Not included

Website

http://www.pyxisoncology.com

Employees

44

Key Details

Price

$0.96(+3.14%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$16.15M

Annual EPS

-$1.32(+28.65% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.96
PYXS price is $0.96

30-Day Relative Volume

0.60
PYXS 30-day relative volume is 0.60

Price Performance

Price Most recent change

+3.14%
PYXS price was up +3.14% on Apr 17, 2025

Price YTD change

-38.25%
PYXS price is down -38.25% since January 1st

Price 1-year change

-80.06%
PYXS price is down -80.06% year-on-year

Price 3-year change

-73.61%
PYXS price is down -73.61% over the past 3 years

Price Range

Price All-time high

$19.00
PYXS price is currently -94.93% below its historical high of $19.00

Price 3-year low

$0.83
PYXS price is currently +15.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$59.33M
PYXS market capitalization is $59.33 million

Market cap 3-year change

-49.79%
PYXS market capitalization is down -49.79% over the past 3 years

Market cap All-time high

$446.61M
PYXS market capitalization is currently -86.72% below its historical high of $446.61 million

Market cap sector rank

40.79%
PYXS market capitalization is higher than 40.79% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+4.74%
PYXS shares outstanding is up +4.74% year-on-year

Shares Outstanding 3-Year Change

+90.24%
PYXS shares outstanding is up +90.24% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.44
PYXS beta is 1.44

200-day SMA

$2.49
PYXS price is currently -61.28% below its 200-day simple moving average

50-day SMA

$1.12
PYXS price is currently -14.12% below its 50-day simple moving average

RSI

45.67
PYXS 14-day relative strength index is 45.67

Volume

0.60
PYXS 30-day relative volume is 0.60

ATR

$0.09
PYXS average true range is $0.09

10-day Historical Volatility

103.26%
PYXS 10-day historical volatility is 103.26%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$16.15M
PYXS annual revenue is $16.15 million

Revenue Analysts estimate

-
PYXS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PYXS annual revenue 1-year change is unknown

Revenue Sector rank

32.51%
PYXS annual revenue is higher than 32.51% of companies in Healthcare sector

EPS

EPS

-$1.32
PYXS annual earnings per share is -$1.32

EPS Analysts estimate

-$1.15
PYXS annual earnings per share is currently +14.45% higher than the consensus analysts' forecast

EPS 1-year change

+28.65%
PYXS annual earnings per share is up +28.65% year-on-year

EPS Sector rank

48.96%
PYXS annual earnings per share is higher than 48.96% of companies in Healthcare sector

Profit

Gross profit

$15.67M
PYXS annual gross profit is $15.67 million

Gross margin

97.06%
PYXS annual gross profit margin is 97.06%

Operating profit

-$68.50M
PYXS annual operating income is -$68.50 million

Operating margin

-424.23%
PYXS annual operating profit margin is -424.23%

Net income

-$77.33M
PYXS annual net profit is -$77.33 million

Net margin

-478.95%
PYXS annual net profit margin is -478.95%

Expenses

Total expenses

$84.64M
PYXS annual total expenses is $84.64 million

Operating expenses

$84.17M
PYXS annual total operating expenses is $84.17 million

Cost of goods sold

$475.00K
PYXS annual cost of goods sold is $475.00 thousand

Selling, general & administrative expenses

$25.42M
PYXS annual SGA is $25.42 million

Depreciation and amortization

$2.98M
PYXS annual depreciation & amortization is $2.98 million

Interest expense

-
PYXS annual interest expense value is unknown

Income tax

-$2.16M
PYXS annual income tax is -$2.16 million

EBIT & EBITDA

EBIT

-$68.50M
PYXS annual earnings before interest & taxes is -$68.50 million

EBITDA

-$65.51M
PYXS annual EBITDA is -$65.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$157.18M
PYXS annual total assets is $157.18 million

Non current assets

$24.74M
PYXS annual long term assets is $24.74 million

Current assets

$132.44M
PYXS annual total current assets is $132.44 million

Cash and cash equivalents

$19.47M
PYXS annual cash & cash equivalents is $19.47 million

Accounts receivable

-
PYXS annual accounts receivable value is unknown

Inventory

-
PYXS annual inventory value is unknown

Liabilities

Total liabilities

$36.43M
PYXS annual total liabilities is $36.43 million

Long term liabilities

$18.75M
PYXS annual total long term liabilities is $18.75 million

Current liabilities

$17.68M
PYXS annual total current liabilities is $17.68 million

Accounts payable

$4.86M
PYXS annual accounts payable is $4.86 million

Debt

Total debt

$20.20M
PYXS annual total debt is $20.20 million

Total debt 1-year change

-5.3%
PYXS annual total debt is down -5.3% year-on-year

Long term debt

$18.75M
PYXS annual long term debt is $18.75 million

Short term debt

$1.45M
PYXS annual short term debt is $1.45 million

Equity & Capital

Shareholders equity

$120.75M
PYXS annual stockholders equity is $120.75 million

Book value

$120.75M
PYXS annual book value is $120.75 million

Retained earnings

-$363.56M
PYXS annual retained earnings is -$363.56 million

Working capital

$114.76M
PYXS annual working capital is $114.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$57.67M
PYXS annual cash flow from operations is -$57.67 million

Cash from operations 1-year change

+18.44%
PYXS annual cash flow from operations is up +18.44% year-on-year

Cash from investing

$8.15M
PYXS annual cash flow from investing activities is $8.15 million

Cash from investing 1-year change

+107.78%
PYXS annual cash flow from investing activities is up +107.78% year-on-year

Cash from financing

$59.33M
PYXS annual cash flow from financing activities is $59.33 million

Cash from financing 1-year change

+900.61%
PYXS annual cash flow from financing activities is up +900.61% year-on-year

CAPEX

CAPEX

$237.00K
PYXS annual capital expenditures is $237.00 thousand

CAPEX 1-year change

-
PYXS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$57.91M
PYXS annual free cash flow is -$57.91 million

Free cash flow 1-year change

+25.22%
PYXS annual free cash flow is up +25.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

97.06%
PYXS annual gross profit margin is 97.06%

Operating margin

-424.23%
PYXS annual operating profit margin is -424.23%

Net margin

-478.95%
PYXS annual net profit margin is -478.95%

ROA & ROE

ROA

-49.20%
PYXS annual return on assets is -49.20%

ROE

-62.75%
PYXS annual return on equity is -62.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PYXS price to earnings ratio value is unknown

PE ratio Sector rank

-
PYXS price to earnings ratio is unknown

PB Ratio

PB ratio

0.49
PYXS price to book ratio is 0.49

PB ratio Sector rank

29.9%
PYXS price to book ratio is higher than 29.9% of companies in Healthcare sector

PS Ratio

PS ratio

-
PYXS price to sales ratio value is unknown

PS ratio Sector rank

-
PYXS price to sales ratio is unknown

Enterprise value

Enterprise value

$60.06M
PYXS enterprise value is $60.06 million

Enterprise value Sector rank

43.93%
PYXS enterprise value is higher than 43.93% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.92
PYXS EV/EBITDA is -0.92

EV/EBITDA Sector rank

44.09%
PYXS EV/EBITDA is higher than 44.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.49
PYXS annual current ratio is 7.49

Quick ratio

-
PYXS annual quick ratio value is unknown

Leverage

Debt to equity

0.00
PYXS annual debt to equity ratio is 0.00

Interest coverage ratio

-
PYXS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PYXS piotroski f-score value is unknown

Altman Z-Score

-2.72
PYXS altman z-score is -2.72

Analyst ratings

Recent major analysts updates

Mar 19, 25 RBC Capital
Outperform
Mar 19, 25 HC Wainwright & Co.
Buy
Dec 20, 24 RBC Capital
Outperform
Dec 20, 24 HC Wainwright & Co.
Buy
Nov 21, 24 William Blair
Market Perform
Nov 21, 24 RBC Capital
Outperform
Nov 21, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Stephens & Co.
Overweight
Sep 19, 24 RBC Capital
Outperform
Aug 16, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

INZY logo
Inozyme Pharma (INZY)
JSPR logo
Jasper Therapeutics (JSPR)
GUTS logo
Fractyl Health (GUTS)
CCLD logo
CareCloud (CCLD)
ASRT logo
Assertio Holdings (ASRT)
ACHL logo
Achilles Therapeutics (ACHL)
VTGN logo
VistaGen Therapeutics (VTGN)
ADVM logo
Adverum Biotechnologies (ADVM)
FORA logo
Forian (FORA)
  • What is the ticker symbol for Pyxis Oncology?
  • Does Pyxis Oncology pay dividends?
  • What sector is Pyxis Oncology in?
  • What industry is Pyxis Oncology in?
  • What country is Pyxis Oncology based in?
  • When did Pyxis Oncology go public?
  • Is Pyxis Oncology in the S&P 500?
  • Is Pyxis Oncology in the NASDAQ 100?
  • Is Pyxis Oncology in the Dow Jones?
  • When was Pyxis Oncology's last earnings report?
  • When does Pyxis Oncology report earnings?
  • Should I buy Pyxis Oncology stock now?

What is the ticker symbol for Pyxis Oncology?

The ticker symbol for Pyxis Oncology is NASDAQ:PYXS

Does Pyxis Oncology pay dividends?

No, Pyxis Oncology does not pay dividends

What sector is Pyxis Oncology in?

Pyxis Oncology is in the Healthcare sector

What industry is Pyxis Oncology in?

Pyxis Oncology is in the Biotechnology industry

What country is Pyxis Oncology based in?

Pyxis Oncology is headquartered in United States

When did Pyxis Oncology go public?

Pyxis Oncology's initial public offering (IPO) was on October 8, 2021

Is Pyxis Oncology in the S&P 500?

No, Pyxis Oncology is not included in the S&P 500 index

Is Pyxis Oncology in the NASDAQ 100?

No, Pyxis Oncology is not included in the NASDAQ 100 index

Is Pyxis Oncology in the Dow Jones?

No, Pyxis Oncology is not included in the Dow Jones index

When was Pyxis Oncology's last earnings report?

Pyxis Oncology's most recent earnings report was on Mar 18, 2025

When does Pyxis Oncology report earnings?

The next expected earnings date for Pyxis Oncology is May 14, 2025

Should I buy Pyxis Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page